TipRanks
Go Ultimate55% OFF

Brendon Buschman Insider Profile

4 Followers

Brendon Buschman, Senior Officer at Medexus Pharmaceuticals Inc, holds 89.54K shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP).

Brendon Buschman's Trading History

MDP
Medexus Pharmaceuticals Inc
Dec 06, 2025Senior OfficerUninformative Sell16.50KC$441.42K
TSE:MDP
Insider Shares: 89.54K (27.62%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 06, 2025Uninformative SellC$16.50K6,227C$2.65――
Feb 11, 2025Informative BuyC$50.05K15,000C$3.34-13.50%―
Nov 22, 2024Uninformative SellC$4.72K2,258C$2.09――
Aug 28, 2024Informative BuyC$12.22K5,000C$2.44+24.40%―
Aug 22, 2024Uninformative SellC$14.10K6,053C$2.33――

You May Also Like

Brendon Buschman insider profile FAQ

What is the percentage of profitable transactions made by Brendon Buschman?
The percentage of profitable transactions made by Brendon Buschman is 67%.
What is the average return per transaction made by Brendon Buschman?
The average return per transaction made by Brendon Buschman is 22.00%.
What stocks does Brendon Buschman hold?
Brendon Buschman holds: TSE:MDP stocks.
What was Brendon Buschman’s latest transaction?
Brendon Buschman’s latest transaction was an Uninformative Sell of C$16.50K.
What was Brendon Buschman's most profitable transaction?
Brendon Buschman’s most profitable transaction was an Informative Buy of TSE:MDP stock on July 3, 2024. The return on the trade was 55.30%.
What is Brendon Buschman's role in Medexus Pharmaceuticals Inc?
Brendon Buschman's role in Medexus Pharmaceuticals Inc is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.